Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-02-14 17:52 Tx date 2024-02-05 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Betts, Norman Murray
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,400
+100,000 vol $0.094 each |
140,000 | |
Filed 2024-02-13 17:48 Tx date 2024-02-05 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Yat, Patrick Najum
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,800
+200,000 vol $0.094 each |
360,000 | |
Filed 2024-02-13 16:22 Tx date 2024-02-05 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Madhani, Bahadur
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,280
+120,000 vol $0.094 each |
415,000 | |
Filed 2024-02-13 14:19 Tx date 2024-02-05 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Odidi, Isa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,000
+500,000 vol $0.094 each |
4,418,940 | |
Filed 2024-02-12 18:17 Tx date 2024-02-05 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Odidi, Amina
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,000
+500,000 vol $0.094 each |
4,418,940 | |
Filed 2024-02-12 17:33 Tx date 2024-02-05 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Graham, Shawn Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,040
+100,000 vol $0.0904 each |
140,000 | |
Filed 2019-11-27 15:50 Tx date 2019-11-26 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
AKYEMPON, CHRISTIAN KWEKU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,050
+5,000 vol $0.21 each |
10,500 | |
Filed 2019-11-20 14:30 Tx date 2019-11-15 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Odidi, Amina
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
+$2,083,333 vol |
$3,583,333 | |
Filed 2019-11-20 14:27 Tx date 2019-11-15 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Odidi, Isa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
+$2,083,333 vol |
$3,583,333 | |
Filed 2019-03-25 Tx date 2018-05-15 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Graham, Shawn Michael
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-03-25 Tx date 2019-03-20 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Powell, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
40,000 | |
Filed 2019-03-25 Tx date 2019-03-20 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Madhani, Bahadur
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
275,000 | |
Filed 2019-03-25 Tx date 2011-02-11 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Powell, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-03-25 Tx date 2019-03-20 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Keirstead, Kenneth
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
255,000 | |
Filed 2019-03-25 Tx date 2019-03-20 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Betts, Norman Murray
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
40,000 | |
Filed 2019-03-25 Tx date 2019-01-08 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Betts, Norman Murray
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-03-25 Tx date 2019-03-20 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Graham, Shawn Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
40,000 | |
Filed 2019-03-25 Tx date 2019-03-20 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Madhani, Bahadur
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
295,000 | |
Filed 2019-03-25 Tx date 2019-03-20 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Keirstead, Kenneth
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
275,000 | |
Filed 2019-03-25 Tx date 2019-03-20 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
AKYEMPON, CHRISTIAN KWEKU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
65,001 | |
Filed 2019-03-22 Tx date 2019-03-20 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Odidi, Amina
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
3,918,940 | |
Filed 2019-03-22 Tx date 2019-03-20 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Yat, Patrick Najum
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
160,000 | |
Filed 2019-03-22 Tx date 2019-03-20 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Odidi, Isa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
3,918,940 | |
Filed 2018-09-05 Tx date 2018-09-04 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
AKYEMPON, CHRISTIAN KWEKU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,500 vol |
5,500 | |
Filed 2018-08-30 Tx date 2018-08-29 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
AKYEMPON, CHRISTIAN KWEKU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,200 vol |
3,000 | |
Filed 2018-05-14 Tx date 2018-05-14 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Patient, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,706
+27,225 vol $0.43 each |
100,000 | |
Filed 2018-05-11 Tx date 2018-05-11 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Patient, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,110
+12,775 vol $0.40 each |
72,775 | |
Filed 2018-05-07 Tx date 2018-05-04 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Patient, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,900
+30,000 vol $0.33 each |
60,000 | |
Filed 2018-05-07 Tx date 2018-05-03 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Patient, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,200
+30,000 vol $0.34 each |
30,000 | |
Filed 2017-12-06 Tx date 2017-11-30 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Patient, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,250
+15,000 vol $1.15 each |
75,000 | |
Filed 2017-12-06 Tx date 2017-11-30 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Keirstead, Kenneth
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,000
+40,000 vol $1.15 each |
215,000 | |
Filed 2017-12-06 Tx date 2017-11-30 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Madhani, Bahadur
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
235,000 | |
Filed 2017-12-05 Tx date 2017-11-30 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
AKYEMPON, CHRISTIAN KWEKU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
45,001 | |
Filed 2017-12-05 Tx date 2017-11-30 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Yat, Patrick Najum
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
120,000 | |
Filed 2017-12-05 Tx date 2017-11-30 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Odidi, Isa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+70,000 vol |
3,418,940 | |
Filed 2017-12-05 Tx date 2017-11-30 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Odidi, Amina
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+70,000 vol |
3,418,940 | |
Filed 2017-12-04 Tx date 2017-11-30 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$46,000
+40,000 vol $1.15 each |
235,000 | |
Filed 2017-12-04 Tx date 2017-12-04 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
+8,660 vol |
102,790 | |
Filed 2017-12-04 Tx date 2017-12-04 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
+8,660 vol |
||
Filed 2017-12-04 Tx date 2017-11-30 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Campbell, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$28,749
+25,000 vol $1.15 each |
85,000 | |
Filed 2017-11-02 Tx date 2017-10-20 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Patient, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
60,000 | |
Filed 2017-11-02 Tx date 2017-09-06 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Patient, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-09-15 Tx date 2017-09-06 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Patient, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-09-07 Tx date 2017-09-06 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
+8,181 vol |
94,130 | |
Filed 2017-07-14 Tx date 2017-07-10 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Campbell, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
60,000 | ||
Filed 2017-06-06 Tx date 2017-06-06 |
$IPCI
INTELLIPHARMACEUTICS INTERNATIONAL INC. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Rights DSU
46 - Compensation for services
|
+3,723 vol |
85,949 |